CN116898932A - External wound medicine and preparation method thereof - Google Patents
External wound medicine and preparation method thereof Download PDFInfo
- Publication number
- CN116898932A CN116898932A CN202310920808.0A CN202310920808A CN116898932A CN 116898932 A CN116898932 A CN 116898932A CN 202310920808 A CN202310920808 A CN 202310920808A CN 116898932 A CN116898932 A CN 116898932A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- grinding
- medicine
- dragon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 57
- 238000002360 preparation method Methods 0.000 title description 7
- 208000027418 Wounds and injury Diseases 0.000 claims abstract description 34
- 206010052428 Wound Diseases 0.000 claims abstract description 31
- 239000000843 powder Substances 0.000 claims abstract description 29
- 238000000227 grinding Methods 0.000 claims abstract description 20
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 9
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims abstract description 9
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 9
- 244000235603 Acacia catechu Species 0.000 claims abstract description 9
- 235000006226 Areca catechu Nutrition 0.000 claims abstract description 9
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 9
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 9
- 239000004863 Frankincense Substances 0.000 claims abstract description 9
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 9
- 235000008282 Sanguisorba officinalis Nutrition 0.000 claims abstract description 9
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 9
- 229940037003 alum Drugs 0.000 claims abstract description 9
- 229940116229 borneol Drugs 0.000 claims abstract description 9
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229910052956 cinnabar Inorganic materials 0.000 claims abstract description 9
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000009136 dragon's blood Substances 0.000 claims abstract description 9
- 239000010440 gypsum Substances 0.000 claims abstract description 9
- 229910052602 gypsum Inorganic materials 0.000 claims abstract description 9
- 244000307697 Agrimonia eupatoria Species 0.000 claims abstract description 8
- 241001313857 Bletilla striata Species 0.000 claims abstract description 8
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 8
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 7
- 240000002834 Paulownia tomentosa Species 0.000 claims abstract description 7
- 235000010678 Paulownia tomentosa Nutrition 0.000 claims abstract description 7
- 241000405414 Rehmannia Species 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 6
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 6
- 235000008291 Poterium sanguisorba Nutrition 0.000 claims abstract description 6
- 238000003756 stirring Methods 0.000 claims abstract description 4
- 240000007171 Imperata cylindrica Species 0.000 claims abstract 3
- 244000173853 Sanguisorba officinalis Species 0.000 claims description 8
- 235000000125 common agrimony Nutrition 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 239000009286 sanguis draxonis Substances 0.000 claims description 6
- 229910002651 NO3 Inorganic materials 0.000 claims description 5
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 5
- 230000000699 topical effect Effects 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 3
- 230000001678 irradiating effect Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 28
- 230000001737 promoting effect Effects 0.000 abstract description 20
- 230000000740 bleeding effect Effects 0.000 abstract description 16
- 230000036407 pain Effects 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 238000005469 granulation Methods 0.000 abstract description 8
- 230000003179 granulation Effects 0.000 abstract description 8
- 206010048038 Wound infection Diseases 0.000 abstract description 6
- 230000008961 swelling Effects 0.000 abstract description 6
- -1 dragon bone Chemical compound 0.000 abstract description 3
- 210000003205 muscle Anatomy 0.000 abstract description 3
- 231100000397 ulcer Toxicity 0.000 abstract description 3
- 230000002040 relaxant effect Effects 0.000 abstract description 2
- 210000002435 tendon Anatomy 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract 2
- 235000016993 Agrimonia Nutrition 0.000 abstract 1
- 201000004624 Dermatitis Diseases 0.000 abstract 1
- 240000004064 Poterium sanguisorba Species 0.000 abstract 1
- 206010040943 Skin Ulcer Diseases 0.000 abstract 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 abstract 1
- 239000010446 mirabilite Substances 0.000 abstract 1
- 239000011505 plaster Substances 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 208000032843 Hemorrhage Diseases 0.000 description 15
- 208000014674 injury Diseases 0.000 description 13
- 229940079593 drug Drugs 0.000 description 9
- 230000035876 healing Effects 0.000 description 9
- 230000008733 trauma Effects 0.000 description 8
- 241001598107 Imperata Species 0.000 description 6
- 235000020639 clam Nutrition 0.000 description 6
- 206010042674 Swelling Diseases 0.000 description 5
- 206010053615 Thermal burn Diseases 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 230000017423 tissue regeneration Effects 0.000 description 5
- 230000023597 hemostasis Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 241000717739 Boswellia sacra Species 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 241000237519 Bivalvia Species 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000004210 Pressure Ulcer Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 208000012260 Accidental injury Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 235000018062 Boswellia Nutrition 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 239000010201 sheng-ji-san Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/28—Mercury; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses an external wound medicine, which is prepared from dragon's blood, clam powder, tung bark, frankincense, cogongrass rhizome, catechu, dragon bone, mirabilite, myrrh, hairyvein agrimonia herb and bud, red halloysite, cinnabar, pearl, bletilla striata, garden burnet root, gypsum, borneol, dried alum and dried rehmannia root, and the powder is prepared by grinding, sieving, mixing and stirring, ultraviolet irradiation and finally bottling. The invention adopts the external application mode, has reasonable medicine compatibility, unique curative effect, high cure rate and direct and rapid efficacy. Has effects of promoting blood circulation, removing blood stasis, relieving swelling and pain, relaxing muscles and tendons, promoting blood circulation, preventing wound infection, promoting granulation, and stopping bleeding. Avoiding the conflict of patients caused by long-term administration of traditional Chinese medicines, and solving the problems of skin allergy and ulcer caused by long-term administration of plaster.
Description
Technical Field
The invention relates to an external medicine, in particular to an external wound medicine and a preparation method thereof.
Background
In daily life and work, accidental injury is unavoidable. Such as mild incised wound, scald and burn, collide, tearing trauma, non-healing wound after operation, various infections complicated with diabetes and the like, can bring mental or physical pain to people.
At present, there are many treatment modes and medicines for various injuries, including external medicines of traditional Chinese medicines or western medicines. However, the treatment effect is affected or is not obvious due to the treatment time and effect. And the problems of scar left after treatment or incomplete healing are also faced in the treatment process. Therefore, it is necessary to develop a trauma Chinese medicine with a certain curative effect, which is a problem to be solved at present.
Disclosure of Invention
In view of the current state of the art, the invention provides an external wound medicine which is used for various traumas, incised wounds, scalds and burns, knocks, severe tearing traumas, unhealed wounds after operation and various infections complicated with diabetes.
The invention also provides a preparation method of the medicine.
The technical scheme of the invention is as follows: a topical medicine for treating wounds is prepared from the following raw materials in parts by weight:
10-30 parts of dragon's blood, 30-50 parts of clam powder, 8-10 parts of tung bark,
40-60 parts of frankincense, 8-10 parts of cogongrass rhizome, 30-40 parts of catechu,
80-90 parts of dragon bone, 20-30 parts of sea nitrate, 30-40 parts of myrrh,
5-10 parts of hairyvein agrimony, 80-100 parts of red halloysite, 20-30 parts of cinnabar,
8-10 parts of pearl, 10-15 parts of bletilla striata, 8-10 parts of garden burnet,
80-90 parts of gypsum, 10-15 parts of borneol, 10-20 parts of dried alum,
10-15 parts of radix rehmanniae.
The invention is prepared from the following raw materials in parts by weight:
10 parts of dragon's blood, 35 parts of clam powder, 8 parts of tung bark,
45 parts of frankincense, 8 parts of cogongrass rhizome, 30 parts of catechu,
80 parts of dragon bone, 20 parts of sea nitrate, 30 parts of myrrh,
5 parts of hairyvein agrimony, 80 parts of red halloysite, 20 parts of cinnabar,
8 parts of pearl, 10 parts of bletilla striata, 8 parts of sanguisorba,
80 parts of gypsum, 10 parts of borneol, 10 parts of dried alum,
10 parts of dried rehmannia root.
The preparation method for the medicine comprises the following steps:
1, mixing the above materials except sanguis Draxonis and Os Draconis, grinding in a wall breaking machine at ambient temperature of no higher than 30 deg.C in spring, autumn and winter, continuously grinding at 32000 rpm for 30 min, and filtering with 80, 120 and 180 mesh sieve to obtain fine powder until the materials have no residue;
2, in summer with the ambient temperature higher than 30 ℃ and the humidity higher than 70%, continuously grinding for no more than 15 minutes, and finishing grinding for 4 times;
taking resina Draconis and dragon bone medicine, continuously grinding for no more than 10 minutes each time, preferably, the medicine temperature is no more than 30 ℃ each time, and grinding again until the medicine is filtered into fine powder by a 180-mesh sieve and no residue exists;
and 4, mixing the ground dragon's blood and the fine powder of the dragon bone medicine with the fine powder of the medicine when the temperature is not more than 30 ℃, stirring the mixture slowly for 20 minutes by a stirrer, then irradiating the mixture for 90 minutes by an ultraviolet lamp to obtain powder, and finally bottling the powder to obtain the finished product.
In the invention, the pharmaceutical dosage form is powder.
Description: the temperature of the medicine must be controlled during grinding, otherwise the curative effect and the preservation time of the medicine are directly affected.
The pharmacological effects of the invention are as follows:
1. dragon's blood, its efficacy is promoting blood circulation to relieve pain, traumatic hemorrhage;
2. clam powder with the effects of inducing diuresis to alleviate edema;
3. cortex tunge, its efficacy is detoxication detumescence, analgesic;
4. olibanum, activating blood circulation to stop pain, detumescence and promoting granulation;
5. lalang grass rhizome for cooling blood and stopping bleeding;
6. catechu has effects of promoting blood circulation, removing blood stasis, stopping bleeding and relieving pain;
7. keel for astringing and inducing astringency, and the ulcer is not healed for a long time;
8. sea nitrate, astringing and stopping bleeding;
9. myrrh, swelling eliminating, granulation promoting, qi regulating, pain relieving, blood circulation activating and stasis removing;
10. herba et Gemma Agrimoniae has effect in stopping bleeding;
11. halloysitum rubrum, astringing for hemostasis, healing sore and promoting granulation;
12. cinnabar, tranquillizing and treating sore wounds;
13. pearl, detoxify and promote tissue regeneration, incised wound, bruise, scald, burn, skin injury;
14. the bletilla striata reduces the activity of platelet factors and coagulates blood in a short time;
15. hemostatic of garden burnet root and various bleeding;
16. gypsum, astringing and promoting granulation;
17. borneol, and has the effects of detumescence and pain relief; together with olibanum and dragon's blood, for treating burns and scalds by treating for Shengjisan;
18. alumen, stopping bleeding and healing sore;
19. dried rehmannia root powder for cooling blood and stopping bleeding.
Among the above, sanguis Draxonis is used as the monarch drug, has sweet and salty taste, is neutral in nature, and can promote the circulation of heart and liver meridians, remove blood stasis and relieve pain, stop bleeding, promote tissue regeneration and heal sores. The clams powder, tung bark and red halloysite are used as ministerial drugs, and the clams powder has the effects of clearing heat, resolving phlegm, promoting diuresis and softening hard masses and is commonly used for carbuncles, gall and the like. Tung Pi is bitter in taste and cold in nature, and can clear heat, promote diuresis, detoxify and alleviate edema, and is mainly used for treating stranguria, hemorrhoids, furuncle, acute mastitis, erysipelas and traumatic injury. For chronic ulcer, it is indicated for damp sore with abscess by water and water retention. Olibanum, myrrh, hairyvein agrimony, cogongrass rhizome, garden burnet root, dried rehmannia root, cinnabar, gypsum, dried alum and the like are taken as adjuvant drugs. Boswellia and myrrh are pungent and bitter in taste and enter heart, liver and spleen meridians, and have the effects of activating blood, promoting qi circulation, relieving pain, reducing swelling and promoting granulation. The hairyvein agrimony can astringe and stop bleeding, and the cogongrass rhizome, the sanguisorba officinalis and the dried rehmannia root cool blood and stop bleeding, so that the blood stops without leaving stasis. Cinnabar is externally used for detoxification, gypsum calcination is used for eliminating dampness and healing sores, promoting granulation and stopping bleeding, and bletilla striata has the effects of disinfection and stopping bleeding, preventing wound infection and the like. The dried alum can detoxify and kill parasites, detumescence and hemostasis, eliminate dampness and relieve itching, remove pathogenic factors and pathogenic factors in the body, expel toxin, dredge blood vessels, relieve symptoms such as swelling and the like. Keel, borneol, catechu and pearl are used as the guiding drugs, and the drugs are matched to play a role in eliminating dampness, and have the effects of promoting tissue regeneration, astringing wound and the like.
Has the effects of sterilizing, stopping bleeding, preventing wound infection, etc. The dried alum can detoxify and kill parasites, detumescence and hemostasis, eliminate dampness and relieve itching, remove pathogenic factors and pathogenic factors in the body, expel toxin, dredge blood vessels, relieve symptoms such as swelling and the like. Keel, borneol, catechu and pearl are used as the guiding drugs, and the drugs are matched to play a role in eliminating dampness, and have the effects of promoting tissue regeneration, astringing wound and the like.
Efficacy: promoting blood circulation, removing blood stasis, preventing wound infection, promoting granulation and stopping bleeding.
The main indications are: it is used for treating various wounds.
The application method of the external medicine comprises the following steps: the medicine is an external wound medicine, when in use, physiological saline is extracted by a syringe, after the wound is repeatedly washed clean, the medicine is directly smeared on an affected part, the medicine is covered and firmly stuck by medical gauze, the medicine is changed once a day, and when the medicine is changed in the next day, the medicine is washed by the physiological saline, and then the medicine is smeared every day.
Drug administration cycle: generally, the trauma can be cured after 3-5 days, and has remarkable treatment effect. No need of taking or injecting any interferon, and is especially suitable for self-rescue application.
The beneficial effects of the invention are as follows: the medicine is used for various injuries, incised wounds, knocks, severe tearing injuries, non-healing wounds after operation and various infections complicated with diabetes. After the use, the Chinese medicinal composition can promote the generation of muscle tissues, heal wounds quickly, inhibit bacterial infection, and leave no or reduce scar residues, and the effective rate is over 96 percent. And has no toxic side effect or adverse reaction, and is a trauma Chinese medicament with high efficiency, economy and no pain treatment.
1. In order to fully illustrate the effect of the invention, 50 patients with trauma are counted after treatment, 50 patients with experiments are counted, 43 patients are obviously 86%, 5 effective patients are 10%, and 2 ineffective patients are counted; the total effective rate is 96%. Because of adopting pure Chinese medicinal materials, the Chinese medicinal preparation has no toxic or side effect, obvious main effect and quick response.
Experiments show that 50 patients are effective and cured, and the treatment effect is very satisfactory through a certain treatment course.
Detailed Description
The external wound medicine of the present invention will be described in further detail.
The preparation method comprises the following steps:
1. taking 10 g of dragon's blood, 30 g of clam powder, 8 g of tung bark, 40 g of frankincense, 8 g of cogongrass rhizome, 30 g of catechu, 80 g of dragon bone, 20 g of sea nitro, 30 g of myrrh, 5 g of hairyvein agrimony, 80 g of red halloysite, 20 g of cinnabar, 8 g of pearl, 10 g of bletilla striata, 8 g of garden burnet root, 80 g of gypsum, 10 g of borneol and 10 g of dried alum,
10 g of dried rehmannia root for later use;
2. mixing the above materials except sanguis Draxonis and Os Draconis, grinding in wall breaking machine at ambient temperature of no higher than 30deg.C in spring, autumn and winter, continuously grinding at 32000 rpm for 30 min, and filtering with 80, 120 and 180 mesh sieve to obtain fine powder until the materials have no residue;
3. the ambient temperature is higher than 30 ℃, the humidity is higher than 70% in summer, the continuous grinding is not more than 15 minutes, and the grinding can be completed in 4 times;
4. taking resina Draconis and Os Draconis, continuously grinding for no more than 10 minutes each time, preferably at an interval of no more than 30 ℃, and grinding again until 180 mesh sieve is filtered into fine powder and no residue exists;
5. mixing the ground sanguis Draxonis and Os Draconis powder with the above powder when the temperature is not higher than 30deg.C, stirring for 20 min, irradiating with ultraviolet lamp for 90 min to obtain powder, and bottling.
Drug administration cycle: generally, the trauma can be cured after 3-5 days, and has remarkable treatment effect. No need of taking or injecting any interferon, and is especially convenient for self-rescue application.
The application method of the external medicine comprises the following steps:
the secondary medicine is an external wound medicine, when in use, physiological saline is extracted by a syringe, the wound is repeatedly washed clean, the medicine is directly smeared on an affected part, the medicine is covered and firmly stuck by medical gauze, the medicine is changed once a day, the medicine is changed the next day, the medicine is washed by the physiological saline, and then the medicine is smeared every day.
The using effect is as follows:
1. the hemostasis time of the common wound is 2-3 minutes, and the pain is relieved in 3-10 minutes;
common wounds are healed in 2-3 days;
2. healing after common wound infection is not healed for 7-15 days;
3. the infection of the drainage tube of the cancer patient is healed after unsealing for 10 to 20 days;
4. wound infection heals 10-20 days after bullet taking from the fire gun wound;
5. healing common bedsores for 15-20 days;
6. healing common scalds and infections is carried out for 7-10 days.
The common wound cure rate is 100%; the mental state and the diet of the patient within one month of the bedsore are good, and the cure rate is 90 percent after the medicine is used.
The invention adopts an external application mode, has reasonable medicine compatibility and unique curative effect. Experiments prove that the traditional Chinese medicine has the effects of promoting blood circulation, removing blood stasis, relieving swelling and pain, relaxing muscles and tendons, promoting blood circulation, promoting tissue regeneration and stopping bleeding, has high cure rate, direct and rapid potency of medicine, no toxic or side effect, low cost, safety and reliability.
Claims (4)
1. A topical medicine for treating wounds is prepared from the following raw materials in parts by weight:
10-30 parts of dragon's blood, 30-50 parts of clam powder, 8-10 parts of tung bark,
40-60 parts of frankincense, 8-10 parts of cogongrass rhizome, 30-40 parts of catechu,
80-90 parts of dragon bone, 20-30 parts of sea nitrate, 30-40 parts of myrrh,
5-10 parts of hairyvein agrimony, 80-100 parts of red halloysite, 20-30 parts of cinnabar,
8-10 parts of pearl, 10-15 parts of bletilla striata, 8-10 parts of garden burnet,
80-90 parts of gypsum, 10-15 parts of borneol, 10-20 parts of dried alum,
10-15 parts of radix rehmanniae.
2. The external wound medicine according to claim 1, which is prepared from the following raw materials in parts by weight:
10 parts of dragon's blood, 35 parts of clam powder, 8 parts of tung bark,
45 parts of frankincense, 8 parts of cogongrass rhizome, 30 parts of catechu,
80 parts of dragon bone, 20 parts of sea nitrate, 30 parts of myrrh,
5 parts of hairyvein agrimony, 80 parts of red halloysite, 20 parts of cinnabar,
8 parts of pearl, 10 parts of bletilla striata, 8 parts of sanguisorba,
80 parts of gypsum, 10 parts of borneol, 10 parts of dried alum,
10 parts of dried rehmannia root.
3. A method for preparing a topical wound medicine according to claim 1 or 2, comprising the steps of:
1) Mixing the above materials except sanguis Draxonis and Os Draconis, grinding in wall breaking machine at ambient temperature of no higher than 30deg.C in spring, autumn and winter, continuously grinding at 32000 rpm for 30 min, and filtering with 80, 120 and 180 mesh sieve to obtain fine powder until the materials have no residue;
2) The ambient temperature is higher than 30 ℃, the humidity is higher than 70% in summer, the continuous grinding is not more than 15 minutes, and the grinding can be completed in 4 times;
3) Taking resina Draconis and Os Draconis, continuously grinding for no more than 10 minutes each time, preferably at an interval of no more than 30 ℃, and grinding again until 180 mesh sieve is filtered into fine powder and no residue exists;
4) Mixing the ground sanguis Draxonis and Os Draconis powder with the above powder when the temperature is not higher than 30deg.C, stirring for 20 min, irradiating with ultraviolet lamp for 90 min to obtain powder, and bottling.
4. A topical wound medicine according to claim 1 or 2, characterized in that the topical wound medicine is a powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310920808.0A CN116898932A (en) | 2023-07-26 | 2023-07-26 | External wound medicine and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310920808.0A CN116898932A (en) | 2023-07-26 | 2023-07-26 | External wound medicine and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116898932A true CN116898932A (en) | 2023-10-20 |
Family
ID=88352907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310920808.0A Pending CN116898932A (en) | 2023-07-26 | 2023-07-26 | External wound medicine and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116898932A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101045133A (en) * | 2007-05-03 | 2007-10-03 | 姚武春 | External use medicine for treating burns or scald or skin lesion, and its preparing method |
| CN101543565A (en) * | 2009-05-19 | 2009-09-30 | 卜继武 | Chinese medicine external-use preparation medicament for treating surgery wound infection and method for producing the same |
| CN104815172A (en) * | 2015-04-20 | 2015-08-05 | 李正银 | Scald ointment as well as preparation method and application method of scald ointment |
| CN109745429A (en) * | 2019-03-13 | 2019-05-14 | 陈柯龙 | A kind of Chinese medicine and preparation method thereof for treating the long disunion of wound |
| CN113244330A (en) * | 2021-05-13 | 2021-08-13 | 邴仕科 | Powder for treating burn and scald and preparation method thereof |
-
2023
- 2023-07-26 CN CN202310920808.0A patent/CN116898932A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101045133A (en) * | 2007-05-03 | 2007-10-03 | 姚武春 | External use medicine for treating burns or scald or skin lesion, and its preparing method |
| CN101543565A (en) * | 2009-05-19 | 2009-09-30 | 卜继武 | Chinese medicine external-use preparation medicament for treating surgery wound infection and method for producing the same |
| CN104815172A (en) * | 2015-04-20 | 2015-08-05 | 李正银 | Scald ointment as well as preparation method and application method of scald ointment |
| CN109745429A (en) * | 2019-03-13 | 2019-05-14 | 陈柯龙 | A kind of Chinese medicine and preparation method thereof for treating the long disunion of wound |
| CN113244330A (en) * | 2021-05-13 | 2021-08-13 | 邴仕科 | Powder for treating burn and scald and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 阚成国，等: "珍珠散对急慢性创面组织修复及碱性成纤维生长因子影响的实验研究", 中医药信息, vol. 32, no. 01, 10 January 2015 (2015-01-10), pages 37 - 39 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101310748B (en) | Ointment for treating empyrosis | |
| CN106728727A (en) | It is a kind of to treat ointment of sore and preparation method thereof | |
| CN101569696A (en) | Chinese medicament for traumatic wound | |
| CN101703651B (en) | Medicament for treating diabetic gangrene | |
| CN102526411A (en) | Chinese medicinal composition for treating surgical wound | |
| WO2012100754A1 (en) | Chinese medicine composition for treating stab wounds, burns, and various traumas | |
| CN103768388A (en) | Traditional Chinese medicine formula for treating scalds, burns and trauma by being singly applied externally | |
| CN113262264A (en) | A Chinese medicinal composition for relieving pain and promoting granulation, and its preparation method | |
| CN116898932A (en) | External wound medicine and preparation method thereof | |
| CN102698086A (en) | Chinese medicinal emulsion for treating bedsore accumulated toxin decay | |
| CN111991471A (en) | A topical Chinese medicinal preparation for treating knife wound, burn and scald, and its preparation method | |
| CN110693817A (en) | External skin cream and preparation method thereof | |
| CN101647952A (en) | Flesh engendering and wound closing medicament for external use | |
| CN101254245A (en) | Fast-healing Chinese herbal medicine burns and scald agent | |
| CN109223931A (en) | A kind of burn cream and preparation method thereof for treating burn | |
| CN109045204A (en) | A kind of herb liquid and preparation method thereof for treating burn and scald | |
| CN112587603B (en) | Traditional Chinese medicine composition for repairing traumatic wound, wound liquid and preparation method thereof | |
| CN1075730C (en) | Wind evil-dispelling, meridian passage-dredging and pus-drawing out medicine powder | |
| CN1351887A (en) | Externally applied Chinese medicine decoction | |
| CN102657824A (en) | Medicine used for treating fracture | |
| CN107095884A (en) | A kind of Eradicates necrotic tissue and promoting muscle growings cream | |
| CN107029072A (en) | A kind of Hibisci Paste with antiinflammatory action | |
| CN1234378C (en) | Fracture setting pellet as bone damage treating traditional Chinese medicine | |
| CN116531460A (en) | Traditional Chinese medicine powder for treating huge bedsores and preparation method thereof | |
| CN113679819A (en) | Bacteriostatic agent for rapidly healing wound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |